قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ AT T cell therapy gives new hope to cancer patients

AT T cell therapy gives new hope to cancer patients



In 2016, a 10th-year student, Sally Nasser, found she had a malignant growth on both lungs. For the first time she was diagnosed with: a tumor, a type of bone cancer called sarcoma, at the age of 10 years. This was her third relapse. – said mother Kamil Nasser. "We said, and Sally said that we were not completely ready to give up."

There was one more last option. Salie joined the trial at Bailor College of Medicine using therapy called CAR T. First, doctors removed some Sally T-cells by infecting white blood cells and genetically modified them to recognize sarcoma cancer as enemy cells that should be destroyed . Millions of these new cells were then laid back into Sally's body, ready to seek and destroy cancer. Of the 1

0 patients, three have a stable disease, and two, including Nasser, have no signs of cancer. Two CAR T treatments are already approved by the FDA for forms of leukemia and lymphomas. Another obstacle is that it works on solid tumors such as lungs, colon and sarcoma.

"Solid tumors, many of which are very and very difficult to cure, represent a huge burden on cancer and morbidity and mortality," said Dr. Louis Weiner of the American Cancer Research Association.

Nasser is now a freshman at the University of Massachusetts in Amherst.

"This is the longest that there has never been a repetition," she said. "It gives me hope that you know that the treatment actually worked."

© 2019 CBS Interactive Inc. All rights reserved.


Source link